ACT-IG

Welcome to the Brand page for “ACT-IG”, which is offered here for Pharmaceutical preparations for human use, pharmaceutical antibodies and their fragments and derivatives, cells and genes that produces antibodies, and fragments of antibodies and derivatives of antibodies, all for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use;granting of licenses to others for the use of industrial property rights and copyright;pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “ACT-IG” is believed to be currently owned by “CHUGAI SEIYAKU KABUSHIKI KAISHA (CHUGAIPHARMACEUTICAL CO., LTD.)”.